Pharmafile Logo

Medscape Education Continues Its Patient-Centric Mission at EHA 2024

- PMLiVE

Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape booth (#H03) where clinicians are invited to learn about our latest advancements.

In addition to seven accepted abstracts across both benign and malignant hematology, focused on acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), classical Hodgkin lymphoma (cHL), myelofibrosis (MF), multiple myeloma (MM), paroxysmal nocturnal hemoglobinuria (PNH), and congenital thrombotic thrombocytopenic purpura (cTTP), and an ePoster in multiple myeloma — all evidencing the efficacy and impact of its education — Medscape will be hosting three groundbreaking patient-centric symposia. Two of these are in partnership with patient advocacy groups and all three have a patient advocate on the expert faculty panel. This is a landmark achievement for any medical education organization, and one that sits perfectly in helping Medscape’s patient-centric mission. 

Integrating the patient voice into disease treatment and patient care is slowly becoming recognized and accepted as a necessary paradigm shift to improve patient outcomes. And Medscape Education, as the leading provider of continuing medical education, has assumed a leadership role in this transformation.

In line with our mission to humanize healthcare and work collaboratively with patients and global patient advocacy organizations as part of our education planning and execution, I am delighted that we are holding three patient-centric independent satellite symposia at this year’s EHA focused on ALL, CLL and MF,” says Victoria Harvey-Jones, PhD, Associate Director of Clinical Strategy at Medscape Oncology Global. “As part of our expert faculty, we have representatives from the Lymphoma Coalition, the Global MPN Scientific Foundation and the Cancer Support Community. Together, they will all shine a much needed light on the patient perspective, sharing the challenges that people living with blood cancers face and how HCPs can best support them.” 

Educating physicians and HCPs on the foundations of patient-centric care—where a patient’s wishes, needs, and concerns are listened to and thoroughly integrated into their treatment plan—has become a priority initiative at Medscape. Last year Medscape collaborated with patient advocates, a global patient advocacy organization, and an expert in psycho-oncology to publish a first-of-its-kind white paper detailing how medical education that integrates patient voices and communication skills alongside crucial disease-oriented education can equip HCPs to open meaningful dialog with their patients and empower them to take a more active role in their treatment. 

Medscape’s presentation at the 2023 Patient Centricity & Engagement Conference in Amsterdam was key in providing evidence-based data about how improved HCP-patient communication can smooth the treatment journey for patients and their families, and how education plays a key role in significantly elevating clinician confidence in approaching treatment in a more holistic, patient-centric way. 

As a sponsor of the 5th Patient Centricity & Collaboration World Congress in February of this year, Medscape further demonstrated its unwavering commitment to inspiring patient empowerment, and the importance of patient centricity in every aspect of patient care — from R&D of novel treatments to disease management to designing a treatment plan, clinical trial or other health solution. And later this month (20th June), Dr Harvey-Jones will once again present at the Patient Centricity & Engagement Conference in London, leveraging new groundbreaking evidence from Medscape’s patient-centric educational activities that support the need and efficacy for the integration of patient-centric approaches in medical education that can be applied at any and all stages of educational design, from planning to execution. 

Medscape Education has a long history—dating back almost 3 decades—as a global leader in providing HCP learners with the most up-to-date medical information. Today, that means taking the lead in CME’s transformation, integrating the patient perspective from planning to execution and ushering in a new healthcare ecosystem that meets and addresses patients as equal partners in their healthcare.“Alongside crucial disease- and treatment-centric conversations as part of our symposia at EHA 2024, our aim is to provide a holistic, all-encompassing approach to education, thereby supporting HCPs to have both knowledgeable and compassionate conversations with their patients,” says Dr Harvey-Jones. “Ultimately, this supports and empowers each person, as well as their family, in shared decision-making, and to live their life as they wish.”

For more information on hematology education at Medscape, please contact Jelena Spyropoulos  or Peter Schoonheim.

 

About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.

This content was provided by Medscape Education Global

Company Details

 Latest Content from  Medscape Education Global 

Medscape Oncology: Delivering Impact at ASH

Medscape Oncology was on-site in New Orleans at ASH 2022. During the 4-day conference, Medscape Oncology hosted educational symposia, interacted with clinicians at our booth, and worked with leading faculty...

Medscape Education: Rare Diseases PAH

Today is Rare Disease Day, February 28.Hear from Helen as she describes in her own words what it’s like to live with PAH, and her perspective as a patient.  To learn...

Medscape Education and M4RD: Together Caring for Rare Disease

We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...

The Need for and Impact of Rare Disease Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...